• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/28

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

28 Cards in this Set

  • Front
  • Back
If you see __ __ __ at the site of tumor, you know that there was an immune reaction.
Mononuclear cell infiltrates.
How do draining lymph nodes change with an immune system response?
Hyperplasia.
MAGE, BAGE, and GAGE genes encode __ antigens. Which T cells detect these?
Melanoma. CTL.
Mucin core proteins are expressed by what three carcinomas? Why can mucin proteins not avoid immune detection?
Breast, ovarian, and pancreatic carcinomas. Mucin is underglycosylated, which allows antigen processing and presentation.
Name the tumor associated antigens associated with the following cancers: breast ca, ovarian ca, prostate ca, liver ca.
Breast - HER2/Nu. Ovarian - Ca125. Prostate - PSA. Liver ca - AFP.
What is the hallmark of malignant disease?
Dedifferentiation.
In terms of tumor association antigens, __ is less specific but more sensitive for ovarian cancer. __ is sensitivity and more specific for prostate cancer.
CA125. PSA.
How is tumor immunity related to self-reactive T cells?
Tumor cells can evade immune responses because the thymus eliminated most of the self-reactive T cells, which could kill the tumor.
If T regulatory cell recruitment is prevented, what does that mean for the immune system’s ability to fight tumors?
Lack of Treg recruitment increases the immune system’s ability to fight the tumor; Tregs = suppression.
Tumor elimination by cyclophosphamide depends on inducing of __ __.
CD+4 T cells.
What is required for therapeutic vaccines to sustain a CTL response?
T helper.
These cells taken from the patient can be used in therapeutic vaccines very well.
Dendritic cells.
Patients that receive DC vaccines must be __.
Immunocompetent.
__ __ __ is contraindicated for DC vaccines.
Advanced metastatic disease.
These two cytokines can induce DC maturation.
TNF-alpha and IL-1b.
__ is the first cellular therapy for cancer approved.
Provenge.
This form of immunotherapy is recommended for immunocompromised patients.
T cell immunotherapy.
This form of T cell immunotherapy shows up to 50% response rates in patients with solid metastatic tumors.
Non-myeloablative lymphodepletion enhancement.
Ontak consists of __ + __. How does it help fight tumors?
IL-2 + diphtheria toxin. It inhibits Treg, which facilitate T cell suppression.
These cytokines are used for passive immunotherapy. Which one can cause depression, neuropathy, and hematologic abnormalities?
IL-2, TNF, IFN-alpha, and IFN-gamma. IL-2.
__ has been largely unsuccessful in treating tumors.
Active immunization.
Chimeric immunotherapy often combines __ and __ with antibodies. What does this conjugation often cause?
Combines drugs and toxins to antibodies. Frequently have systemic effects and hepatoxicity.
Rituximab is recombined anti-_.
Anti-CD20.
Herceptin is specific against __.
HER2-neu.
Avastin inhibits __ and is used against colorectal cancer.
Inhibits VEGF.
Name four ways that tumors can evade immune detection.
Decreased HLA class expression, decreased costimulatory molecules for T cell activation, secretion of immunosuppressive cytokines, and expression of chemokines that drive Treg recruitment.
How do you distinguish between B and T cell lymphomas?
Immunohistochemistry shows that B cell lymphomas express CD19 and CD20 while T cell lymphomas express CD25.
Which cell surface antigen does Burkitt lymphoma express?
CD10.